Trial Profile
Effects of p38 Inhibitor AZD7624 in Corticosteroid Resistant Asthma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs AZD 7624 (Primary) ; Prednisone
- Indications Asthma
- Focus Pharmacodynamics
- 08 Aug 2019 Status changed from recruiting to completed.
- 03 Jan 2017 Planned End Date changed from 1 Jan 2017 to 1 Jan 2018.
- 03 Jan 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Jan 2018.